[1]
|
Njoroge, J.N. and Teerlink, J.R. (2021) Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure. Circulation Research, 128, 1468-1486. https://doi.org/10.1161/CIRCRESAHA.121.318186
|
[2]
|
Xanthopoulos, A., Butler, J., Parissis, J., et al. (2020) Acutely Decompensated versus Acute Heart Failure: Two Different Entities. Heart Failure Reviews, 25, 907-916. https://doi.org/10.1007/s10741-019-09894-y
|
[3]
|
Raj, L., Maidman, S.D. and Adhyaru, B. (2020) Inpatient Man-agement of Acute Decompensated Heart Failure. Postgraduate Medical Journal, 96, 33-42. https://doi.org/10.1136/postgradmedj-2019-136742
|
[4]
|
Kurmani, S. and Squire, I. (2017) Acute Heart Failure: Definition, Classification and Epidemiology. Current Heart Failure Reports, 14, 385-392. https://doi.org/10.1007/s11897-017-0351-y
|
[5]
|
Burger, A., Horton, D., Lejemtel, T., et al. (2002) Effect of Nesiritide (B-Type Natriuretic Peptide) and Dobutamine on Ventricular Arrhythmias in the Treatment of Patients with Acutely Decompensated Congestive Heart Failure: The PRECEDENT Study. American Heart Journal, 144, 1102-1108. https://doi.org/10.1067/mhj.2002.125620
|
[6]
|
Parissis, J.T., Rafouli-Stergiou, P., Paraskevaidis, I. and Mebazaa, A. (2009) Levosimendan: From Basic Science to Clinical Practice. Heart Failure Reviews, 14, 265-275. https://doi.org/10.1007/s10741-008-9128-4
|
[7]
|
Cohen-Solal, A., Logeart, D., Huang, B., et al. (2009) Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated with Improved Sur-vival in Patients with Severe Acutely Decompensated Heart Failure. Journal of the American College of Cardiology, 53, 2343-2348.
https://doi.org/10.1016/j.jacc.2009.02.058
|
[8]
|
Landoni, G., Biondi-Zoccai, G., Greco, M., et al. (2012) Effects of Levosimendan on Mortality and Hospitalization. A Meta-Analysis of Randomized Controlled Studies. Critical Care Medicine, 40, 634-646.
https://doi.org/10.1097/CCM.0b013e318232962a
|
[9]
|
Forzano, I., Mone, P., Mottola, G., et al. (2022) Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure. Journal of Clinical Medicine, 11, Article No. 7503. https://doi.org/10.3390/jcm11247503
|
[10]
|
Sabbah, H.N., Imai, M., Cowart, D., et al. (2007) Hemodynamic Prop-erties of a New-Generation Positive Luso-Inotropic Agent for the Acute Treatment of Advanced Heart Failure. The American Journal of Cardiology, 99, S41-S46.
https://doi.org/10.1016/j.amjcard.2006.09.005
|
[11]
|
Feil, R., Lohmann, S., De Jonge, H., Walter, U. and Hofmann, F. (2003) Cyclic GMP-Dependent Protein Kinases and the Cardiovascular System: Insights from Genetically Modified Mice. Circulation Research, 93, 907-916.
https://doi.org/10.1161/01.RES.0000100390.68771.CC
|
[12]
|
Burger, A.J. (2005) A Review of the Renal and Neu-rohormonal Effects of B-Type Natriuretic Peptide. Congestive Heart Failure, 11, 30-38. https://doi.org/10.1111/j.1527-5299.2005.03794.x
|
[13]
|
Kapoun, A.M., Liang, F., O’Young, G., et al. (2004) B-Type Natriuretic Peptide Exerts Broad Functional Opposition to Transforming Growth Factor-β in Primary Human Cardiac Fibroblasts: Fibrosis, Myofibroblast Conversion, Proliferation, and Inflammation. Circulation Research, 94, 453-461. https://doi.org/10.1161/01.RES.0000117070.86556.9F
|
[14]
|
Mitter, S.S. and Pinney, S.P. (2020) Ad-vances in the Management of Acute Decompensated Heart Failure. Medical Clinics of North America, 104, 601-14. https://doi.org/10.1016/j.mcna.2020.03.002
|
[15]
|
Grygier, M., Araszkiewicz, A., Lesiak, M. and Grajek, S. (2013) Effect of New Method of Intracoronary Adenosine Injection during Primary Percutaneous Coronary Intervention on Mi-crovascular Reperfusion Injury—Clinical Outcome and 1-Year Follow-up. Cardiology, 124, 199-206. https://doi.org/10.1159/000346876
|
[16]
|
Zhu, X.Q., Hong, .S.H, Lin, X.H., Chen, L.L. and Li, Y.H. (2014) Changes in Cardiac Aldosterone and Its Synthase in Rats with Chronic Heart Failure: An Intervention Study of Long-Term Treatment with Recombinant Human Brain Natriuretic Peptide. Brazilian Journal of Medical and Biological Research/Revista Brasileira de Pesquisas Medicas e Biologicas, 47, 646-654. https://doi.org/10.1590/1414-431x20143474
|
[17]
|
O’Connor, C.M., Stough, W.G., Gallup, D.S., Hasselblad, V. and Gheorghiade, M. (2005) Demographics, Clinical Characteristics, and Outcomes of Patients Hospitalized for Decom-pensated Heart Failure: Observations from the IMPACT-HF Registry. Journal of Cardiac Failure, 11, 200-205. https://doi.org/10.1016/j.cardfail.2004.08.160
|
[18]
|
Gheorghiade, M., Gattis, W., O’Connor, C.M., et al. (2004) Ef-fects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized with Worsening Heart Failure: A Randomized Controlled Trial. JAMA, 291, 1963-19971.
https://doi.org/10.1001/jama.291.16.1963
|
[19]
|
Fukunami, M., Matsuzaki, M., Hori, M., et al. (2011) Efficacy and Safety of Tolvaptan in Heart Failure Patients with Sustained Volume Overload despite the Use of Conventional Diuretics: A Phase III Open-Label Study. Cardiovascular Drugs and Therapy, 25, 47-56. https://doi.org/10.1007/s10557-011-6348-y
|
[20]
|
Mori, T., Oba, I., Koizumi, K., et al. (2013) Beneficial Role of Tolvaptan in the Control of Body Fluids without Reductions in Residual Renal Function in Patients Undergoing Perito-neal Dialysis. Advances in Peritoneal Dialysis, 29, 33-37.
|
[21]
|
Sargento, L., Satendra, M., Longo, S., Lousada, N. and dos Reis, R.P. (2014) Heart Rate Reduction with Ivabradine in Patients with Acute Decompensated Systolic Heart Failure. American Journal of Cardiovascular Drugs, 14, 229-235.
https://doi.org/10.1007/s40256-013-0060-1
|
[22]
|
Custodis, F., Reil, J.-C., Laufs, U. and Böhm, M. (2013) Heart Rate: A Global Target for Cardiovascular Disease and Therapy Along the Cardiovascular Disease Continuum. Journal of Cardiology, 62, 183-187.
https://doi.org/10.1016/j.jjcc.2013.02.018
|
[23]
|
Böhm, M., Swedberg, K., Komajda, M., et al. (2010) Heart Rate as a Risk Factor in Chronic Heart Failure (SHIFT): The Association between Heart Rate and Outcomes in a Randomised Placebo-Controlled Trial. Lancet, 376, 886-894.
https://doi.org/10.1016/S0140-6736(10)61259-7
|
[24]
|
Habal, M.V., Liu, P.P., Austin, P.C., et al. (2014) Associa-tion of Heart Rate at Hospital Discharge with Mortality and Hospitalizations in Patients with Heart Failure. Circulation: Heart Failure, 7, 12-20.
https://doi.org/10.1161/CIRCHEARTFAILURE.113.000429
|
[25]
|
Borer, J.S., Böhm, M., Ford, I., et al. (2014) Ef-ficacy and Safety of Ivabradine in Patients with Severe Chronic Systolic Heart Failure (from the SHIFT Study). The American Journal of Cardiology, 113, 497-503.
https://doi.org/10.1016/j.amjcard.2013.10.033
|
[26]
|
Böhm, M., Borer, J.S., Camm, J., et al. (2015) Twen-ty-Four-Hour Heart Rate Lowering with Ivabradine in Chronic Heart Failure: Insights from the SHIFT Holter Substudy. European Journal of Heart Failure, 17, 518-526.
https://doi.org/10.1002/ejhf.258
|
[27]
|
Böhm, M., Robertson, M., Ford, I., et al. (2015) Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction with Ivabradine in Stable Heart Failure (from the SHIFT Trial). The American Journal of Cardiology, 116, 1890-1897. https://doi.org/10.1016/j.amjcard.2015.09.029
|
[28]
|
Vagnarelli, F., Marini, M., Caretta, G., et al. (2017) [Noninva-sive Ventilation: General Characteristics, Indications, and Review of the Literature]. Giornale Italiano di Cardiologia, 18, 496-504. (In Italian)
|
[29]
|
Moss, M., Nordon-Craft, A., Malone, D., et al. (2016) A Randomized Trial of an Intensive Physical Therapy Program for Patients with Acute Respiratory Failure. American Journal of Respiratory and Critical Care Medicine, 193, 1101-1110. https://doi.org/10.1164/rccm.201505-1039OC
|
[30]
|
Thille, A.W., Esteban, A., Fernández-Segoviano, P., et al. (2013) Comparison of the Berlin Definition for Acute Respiratory Distress Syndrome with Autopsy. American Journal of Respiratory and Critical Care Medicine, 187, 761-767.
https://doi.org/10.1164/rccm.201211-1981OC
|
[31]
|
Moret Iurilli, C., Brunetti, N., Di Corato, P., et al. (2018) Hy-peracute Hemodynamic Effects of BiPAP Noninvasive Ventilation in Patients with Acute Heart Failure and Left Ventric-ular Systolic Dysfunction in Emergency Department. Journal of Intensive Care Medicine, 33, 128-133. https://doi.org/10.1177/0885066617740849
|
[32]
|
Ezekowitz, J.A., Hu, J., Delgado, D., et al. (2012) Acute Heart Failure: Perspectives from a Randomized Trial and a Simultaneous Registry. Circulation: Heart Failure, 5, 735-741.
https://doi.org/10.1161/CIRCHEARTFAILURE.112.968974
|
[33]
|
Sharma, A., Hermann, D.D. and Mehta, R.L. (2001) Clinical Benefit and Approach of Ultrafiltration in Acute Heart Failure. Cardiology, 96, 144-154. https://doi.org/10.1159/000047398
|
[34]
|
Umer, N., Makki, M., Kiran, S.K. and Jadoon, N.A. (2017) Serum Ferritin as a Predictor of 30 Days Mortality in Patients of Decompensated Chronic Liver Disease. Journal of Ayub Medical Col-lege Abbottabad, 29, 415-418.
|
[35]
|
Briyal, S., Shah, S. and Gulati, A. (2014) Neuroprotective and Anti-Apoptotic Ef-fects of Liraglutide in the Rat Brain Following Focal Cerebral Ischemia. Neuroscience, 281, 269-281. https://doi.org/10.1016/j.neuroscience.2014.09.064
|
[36]
|
Demiselle, J., Besson, V., Sayegh, J.-F. and Augusto, J.-F. (2016) Total Artificial Heart and Chronic Haemodialysis: A Possible Bridge to Transplantation? Blood Purification, 42, 301-303. https://doi.org/10.1159/000448162
|
[37]
|
Hall, J.L., Fermin, D.R., Birks, E.J., et al. (2011) Clinical, Molecular, and Genomic Changes in Response to a Left Ventricular Assist Device. Journal of the American College of Cardiology, 57, 641-652.
https://doi.org/10.1016/j.jacc.2010.11.010
|
[38]
|
Undar, A. and Wang, S. (2013) Current Devices for Pediatric Ex-tracorporeal Life Support and Mechanical Circulatory Support Systems in the United States. Bio-Medical Materials and Engineering, 23, 57-62.
https://doi.org/10.3233/BME-120732
|
[39]
|
Starling, R.C., Naka, Y., Boyle, A.J., et al. (2011) Results of the Post-U.S. Food and Drug Administration-Approval Study with a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation: A Prospective Study Using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). Journal of the American College of Cardiology, 57, 1890-1898. https://doi.org/10.1016/j.jacc.2010.10.062
|
[40]
|
Lian, R., Zhang, G., Yan, S., et al. (2018) Role of Ultrasound Lung Comets in the Diagnosis of Acute Heart Failure in Emergency Department: A Systematic Review and Meta-Analysis. Biomedical and Environmental Sciences, 31, 596-607.
|
[41]
|
Maciver, J. and Ross, H. (2012) Quality of Life and Left Ventricular Assist Device Support. Circulation, 126, 866-874.
https://doi.org/10.1161/CIRCULATIONAHA.111.040279
|